Compare Global X CleanTech (CTEC) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X CleanTech vs GSK plc — how do they compare? Global X CleanTech trades at $55.45 (market cap $24.57M), while GSK plc trades at $46.82 (market cap $91.88B). The key difference: GSK plc is far larger — about 3739.5× Global X CleanTech's market cap, and GSK plc pays a 3.9% dividend while Global X CleanTech pays none. Which is the better fit depends on your goals — on Pluang, investors hold Global X CleanTech for 42 Days and GSK plc for 93 Days on average.
| CTEC | GSK | |
|---|---|---|
Market Cap | $24.57M | $91.88B |
Volume | 1,220 | 7,730,529 |
Sector | Sector/Thematic | Health |
52-Week High | $78.11 | $61.18 |
52-Week Low | $50.82 | $43.24 |
Typical Hold Time | 42 Days | 93 Days |
Enterprise Value | — | $111.88B |
Dividend Yield | — | 3.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GSK trades at $47.02, up 0.9% today, with a bearish technical signal but strong fundamentals. The company reported revenue of $32.67B in 2025 with a net income margin of 14.52% and has beaten EPS estimates for three consecutive quarters. Recent news highlights strategic oncology investments and a $750M deal for a cancer therapy, signaling growth initiatives.
The outlook is mixed: solid profitability and a reasonable P/E of 15.1 support value, but technical indicators show bearish pressure near key support at $46. Risks include patent expirations and competitive pressures, while analyst sentiment is cautious with 31% buy ratings. Upside depends on pipeline execution and cost savings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Global X CleanTech
CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.
Read more on CTEC →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
